Skip to main content
Top
Published in: Acta Diabetologica 1/2008

01-03-2008 | Original Article

Prevalence and associated factors of lens opacities among Chinese type 2 diabetics in Kinmen, Taiwan

Authors: Shih-Jen Chen, Jorn-Hon Liu, Hui-Chuan Shih, Pesus Chou, Ching-Yao Tsai, Tao-Hsin Tung

Published in: Acta Diabetologica | Issue 1/2008

Login to get access

Abstract

The aim of this study is to assess the prevalence and associated risk factors of lens opacities among type 2 diabetics in Kinmen, Taiwan. A community-based mass screening ascertained 971 type 2 diabetics from 1991 to 1993. From that population, a total of 578 (59.5%) patients with type 2 diabetes underwent eye screening in 1999 with a 45° thin slit-lamp biomicroscopy and ophthalmoscopy to examine the lens after dilation of the pupils. The prevalence of nuclear, cortical, and posterior subcapsular (PSC) opacity without surgery among type 2 diabetics was 22.5, 20.2, and 19.9%, respectively. The number of females affected was statistically higher than males in each type of lens opacity. The prevalence of each type of lens opacity also showed a statistically significant increase with (χ2 test). Based on multiple logistic regressions, age was the most significant factor related with each type of lens opacity. Triglyceride at baseline was associated with nuclear opacity (≥200 vs. <200 mg/dl, OR = 2.35, 95% CI: 1.15–4.79) and PSC opacity (≥200 vs. <200 mg/dl, OR = 2.11, 95% CI: 1.00–4.43). In conclusion, our results show that in addition to age, higher triglyceride level may increase the risk of prevalent nuclear or PSC opacity in type 2 diabetics.
Literature
1.
go back to reference Klein R, Klein BEK, Moss SE (1984) Visual impairment in diabetes. Ophthalmology 91:1–8PubMed Klein R, Klein BEK, Moss SE (1984) Visual impairment in diabetes. Ophthalmology 91:1–8PubMed
2.
go back to reference Ederer F, Hiller R, Taylor HR (1981) Senile lens changes and diabetes in two population studies. Am J Ophthalmol 91:381–395PubMed Ederer F, Hiller R, Taylor HR (1981) Senile lens changes and diabetes in two population studies. Am J Ophthalmol 91:381–395PubMed
3.
go back to reference Klein BEK, Klein R, Moss MS (1985) Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 92:1191–1196PubMed Klein BEK, Klein R, Moss MS (1985) Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 92:1191–1196PubMed
4.
go back to reference Steinberg EP, Tielsch JM, Schein OD et al (1994) The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol 112:630–638PubMed Steinberg EP, Tielsch JM, Schein OD et al (1994) The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol 112:630–638PubMed
5.
go back to reference He M, Xu J, Li S et al (1999) Visual acuity and quality of life in patients with cataract in Doumen county, China. Ophthalmology 106:1609–1615PubMedCrossRef He M, Xu J, Li S et al (1999) Visual acuity and quality of life in patients with cataract in Doumen county, China. Ophthalmology 106:1609–1615PubMedCrossRef
6.
go back to reference Zhao J, Sui R, Jia L et al (1998) Visual acuity and quality of life outcomes in patients with cataract in Shunyi county, China. Am J Ophthalmol 126:515–523PubMedCrossRef Zhao J, Sui R, Jia L et al (1998) Visual acuity and quality of life outcomes in patients with cataract in Shunyi county, China. Am J Ophthalmol 126:515–523PubMedCrossRef
7.
go back to reference Klein BEK, Klein R, Lee KE (1998) Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126:782–790PubMedCrossRef Klein BEK, Klein R, Lee KE (1998) Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126:782–790PubMedCrossRef
8.
go back to reference Tung TH, Liu JH, Lee FL et al (2005) Community-based study of cataracts among type 2 diabetics in Kinmen. Eur J Epidemiol 20:435–441PubMedCrossRef Tung TH, Liu JH, Lee FL et al (2005) Community-based study of cataracts among type 2 diabetics in Kinmen. Eur J Epidemiol 20:435–441PubMedCrossRef
9.
go back to reference Tsai CY, Tung TH, Woung LC et al (2007) Population-based study of cataract surgery among patients with type 2 diabetes in Kinmen, Taiwan. Can J Ophthalmol 42:262–267PubMedCrossRef Tsai CY, Tung TH, Woung LC et al (2007) Population-based study of cataract surgery among patients with type 2 diabetes in Kinmen, Taiwan. Can J Ophthalmol 42:262–267PubMedCrossRef
10.
go back to reference Chou P, Liao M J, Kuo HS et al (1994) A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care 17:1055–1058PubMedCrossRef Chou P, Liao M J, Kuo HS et al (1994) A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care 17:1055–1058PubMedCrossRef
11.
go back to reference World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
12.
go back to reference Stratton IM, Alder AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412PubMedCrossRef Stratton IM, Alder AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412PubMedCrossRef
13.
go back to reference Early Treatment diabetic retinopathy study research group (1991) Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 98:766–785 Early Treatment diabetic retinopathy study research group (1991) Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 98:766–785
14.
go back to reference Wilkinson CP, Ferris FL, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682PubMedCrossRef Wilkinson CP, Ferris FL, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682PubMedCrossRef
15.
go back to reference Tsai SY, Hsu WM, Cheng CY et al (2003) Epidemiologic study of age-related cataracts among an elderly Chinese population in Shihpai, Taiwan. Ophthalmology 110:1089–1095PubMedCrossRef Tsai SY, Hsu WM, Cheng CY et al (2003) Epidemiologic study of age-related cataracts among an elderly Chinese population in Shihpai, Taiwan. Ophthalmology 110:1089–1095PubMedCrossRef
16.
go back to reference Chylack LT Jr, Wolfe JK, Singer DM.et al (1993) The lens opacities classification system III. The longitudinal study of cataract study group. Arch Ophthalmol 111:831–836PubMed Chylack LT Jr, Wolfe JK, Singer DM.et al (1993) The lens opacities classification system III. The longitudinal study of cataract study group. Arch Ophthalmol 111:831–836PubMed
17.
go back to reference Cheng CY, Liu JH, Chen SJ et al (2000) Population-based study on prevalence and risk factors of age-related cataracts in Peitou, Taiwan. Chin Med J (Taipei) 63:641–648 Cheng CY, Liu JH, Chen SJ et al (2000) Population-based study on prevalence and risk factors of age-related cataracts in Peitou, Taiwan. Chin Med J (Taipei) 63:641–648
18.
go back to reference Mitchell P, Cumming RG, Attebo K et al (1997) Prevalence of cataract in Australia: the Blue Mountain eye study. Ophthalmology 104:581–588PubMed Mitchell P, Cumming RG, Attebo K et al (1997) Prevalence of cataract in Australia: the Blue Mountain eye study. Ophthalmology 104:581–588PubMed
19.
go back to reference Seah SKL, Wong TY, Foster PJ et al (2002) Prevalence of lens opacity in Chinese residents of Singapore: the Tanjong Pager survey. Ophthalmology 109:2058–2064PubMedCrossRef Seah SKL, Wong TY, Foster PJ et al (2002) Prevalence of lens opacity in Chinese residents of Singapore: the Tanjong Pager survey. Ophthalmology 109:2058–2064PubMedCrossRef
20.
go back to reference West SK, Valmadrid CT (1995) Epidemiology of risk factors for age-related cataract. Surv Ophthalmol 39:323–334PubMedCrossRef West SK, Valmadrid CT (1995) Epidemiology of risk factors for age-related cataract. Surv Ophthalmol 39:323–334PubMedCrossRef
21.
go back to reference Wong TY, Klein R, Klein BEK et al (2001) Refractive errors and age-related cataract: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 42:449–454 Wong TY, Klein R, Klein BEK et al (2001) Refractive errors and age-related cataract: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 42:449–454
22.
go back to reference Leske MC, Chylack LT Jr, Wu SY (1991) The lens opacities case-control study group. The lens opacities case-control study. Risk factors for cataract. Arch Ophthalmol 109:244–251PubMed Leske MC, Chylack LT Jr, Wu SY (1991) The lens opacities case-control study group. The lens opacities case-control study. Risk factors for cataract. Arch Ophthalmol 109:244–251PubMed
23.
go back to reference Hammond CJ, Snieder H, Spector TD et al (2000) Genetic and environment factors in age-related nuclear cataracts in monozygotic and dizygotic twins. N Engl J Med 342:1786–1790PubMedCrossRef Hammond CJ, Snieder H, Spector TD et al (2000) Genetic and environment factors in age-related nuclear cataracts in monozygotic and dizygotic twins. N Engl J Med 342:1786–1790PubMedCrossRef
24.
go back to reference Chatterjee A, Milton RC, Thyle S (1982) Prevalence and aetiology of cataract in Punjab. Br J Ophthalmol 66:35–42PubMedCrossRef Chatterjee A, Milton RC, Thyle S (1982) Prevalence and aetiology of cataract in Punjab. Br J Ophthalmol 66:35–42PubMedCrossRef
25.
go back to reference Klein BEK, Klein R, Ritter LL (1994) Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye study. Arch Ophthalmol 112:85–91PubMed Klein BEK, Klein R, Ritter LL (1994) Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye study. Arch Ophthalmol 112:85–91PubMed
26.
go back to reference Kim SI, Kim SJ (2006) Prevalence and risk factors for cataracts in persons with type 2 diabetes mellitus. Korean J Ophthalmol 20:201–204PubMedCrossRef Kim SI, Kim SJ (2006) Prevalence and risk factors for cataracts in persons with type 2 diabetes mellitus. Korean J Ophthalmol 20:201–204PubMedCrossRef
27.
go back to reference Klein BEK, Klein R, Moss SE (1995) Incidence of cataract surgery in the Wisconsin epidemiologic study of diabetic retinopathy. Am J Ophthalmol 119:295–300PubMed Klein BEK, Klein R, Moss SE (1995) Incidence of cataract surgery in the Wisconsin epidemiologic study of diabetic retinopathy. Am J Ophthalmol 119:295–300PubMed
28.
go back to reference Klein BEK, Klein R, Jensen SC et al (1995) Hypertension and lens opacities from the Beaver Dam Eye study. Am J Ophthalmol 119:640–646PubMed Klein BEK, Klein R, Jensen SC et al (1995) Hypertension and lens opacities from the Beaver Dam Eye study. Am J Ophthalmol 119:640–646PubMed
29.
go back to reference Schaumberg DA, Glynn RJ, Christen WG et al (2001) A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol 11:104–110PubMedCrossRef Schaumberg DA, Glynn RJ, Christen WG et al (2001) A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol 11:104–110PubMedCrossRef
30.
go back to reference Leske MC, Chylack LT, He Q et al (1998) Risk factors for nuclear opalescence in a longitudinal study. LSC group. Longitudinal study of cataract. Am J Epidemiol 147:36–41PubMed Leske MC, Chylack LT, He Q et al (1998) Risk factors for nuclear opalescence in a longitudinal study. LSC group. Longitudinal study of cataract. Am J Epidemiol 147:36–41PubMed
31.
go back to reference Hiller R, Sperduto RD, Ederer F (1986) Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol 124:916–925PubMed Hiller R, Sperduto RD, Ederer F (1986) Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol 124:916–925PubMed
32.
go back to reference Mohan M, Sperduto RD, Angra SK et al (1989) India–US case-control study of age-related cataracts. Arch Ophthalmol 107:670–676PubMed Mohan M, Sperduto RD, Angra SK et al (1989) India–US case-control study of age-related cataracts. Arch Ophthalmol 107:670–676PubMed
33.
go back to reference Chen TT, Hockwin O, Dobbs R et al (1988) Cataract and health status: a case-control study. Ophthalmic Res 20:1–9PubMed Chen TT, Hockwin O, Dobbs R et al (1988) Cataract and health status: a case-control study. Ophthalmic Res 20:1–9PubMed
34.
go back to reference Hiller R, Sperduto RD, Reed GF et al (2003) Serum lipids and age-related lens opacities: a longitudinal investigation. The Framingham studies. Ophthalmology 110:578–583PubMedCrossRef Hiller R, Sperduto RD, Reed GF et al (2003) Serum lipids and age-related lens opacities: a longitudinal investigation. The Framingham studies. Ophthalmology 110:578–583PubMedCrossRef
35.
go back to reference Janh CE, Janke M, Winowsk H et al (1986) Identification of metabolic risk factors for posterior subcapsular cataract. Ophthalmic Res 18:112–116 Janh CE, Janke M, Winowsk H et al (1986) Identification of metabolic risk factors for posterior subcapsular cataract. Ophthalmic Res 18:112–116
36.
go back to reference Tsutsumi K, Inoue Y, Yoshida C (1999) Acceleration of development of diabetic cataract by hyperlipidemia and low high density lipoprotein rats. Biol Pharm Bull 22:37–41PubMed Tsutsumi K, Inoue Y, Yoshida C (1999) Acceleration of development of diabetic cataract by hyperlipidemia and low high density lipoprotein rats. Biol Pharm Bull 22:37–41PubMed
Metadata
Title
Prevalence and associated factors of lens opacities among Chinese type 2 diabetics in Kinmen, Taiwan
Authors
Shih-Jen Chen
Jorn-Hon Liu
Hui-Chuan Shih
Pesus Chou
Ching-Yao Tsai
Tao-Hsin Tung
Publication date
01-03-2008
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2008
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-007-0012-9

Other articles of this Issue 1/2008

Acta Diabetologica 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.